R&D

Bayer bets $1.5B that Vividion will help it target the 'undruggable' and make 1+1=3
Fierce Biotech
Thu, 08/5/21 - 11:11 am
Bayer
Vividion
M&A
IPOs
R&D
Eli Lilly hands Kumquat Biosciences $70M to kick off cancer drug R&D alliance
MedCity News
Thu, 07/29/21 - 11:03 am
Eli Lilly
Kumquat Biosciences
R&D
immuno-oncology
cancer
AI breakthrough could spark medical revolution
BBC News
Sun, 07/25/21 - 11:51 am
DeepMind
Google
artificial intelligence
proteins
R&D
drug discovery
Regeneron plans $1.8bn investment to expand research facilities in New York, US
Pharmaceutical Business Review
Fri, 07/16/21 - 10:39 am
Regeneron
New York
R&D
BioBonds Would Use Wall St. Tools to Fund Medical Research
NY Times, NY
Mon, 07/12/21 - 11:45 pm
funding
R&D
BioBonds
legistlation
Gates Foundation backs COVID R&D at AI firm Exscientia
Pharmaforum
Thu, 07/8/21 - 11:01 am
Gates Foundation
Exscientia
R&D
COVID-19
artificial intelligence
Almirall kicks off another hunt for skin disease therapy partnerships
Pharmaforum
Mon, 07/5/21 - 10:02 pm
Almirall
dermatology
R&D
Drug R&D is broken; how to put the tech in biotech
MedCity News
Thu, 07/1/21 - 10:31 am
R&D
Medtech
biotech
pandemic
Getting under your skin: Sorrento leveraging novel drug delivery platform to treat melanoma in tie-up with Mayo Clinic
BioPharma Dive
Thu, 06/17/21 - 11:06 am
Sorrento Therapeutics
melanoma
R&D
Mayo Clinic
Lilly helps Circle round up $66M for intractable target R&D
Fierce Biotech
Thu, 06/17/21 - 10:56 am
Circle Pharma
cyclin
Eli Lilly
R&D
funding
Italy sees hike in biotech R&D investments, at rate higher than EU average
Biopharma Reporter
Wed, 06/2/21 - 11:05 am
Italy
biotech
R&D
Centessa Pharma’s IPO brings in $330M for its new model of drug R&D
MedCity News
Tue, 06/1/21 - 10:59 am
IPOs
Centessa Pharmaceuticals
R&D
Researchers in biotech, academia and Big Pharma are offering puzzle pieces to crack CAR-T for solid tumors. Will they ever snap together?
Endpoints
Wed, 05/26/21 - 11:01 am
R&D
solid tumors
CAR-T
AI, big data and real world evidence – the challenges and opportunities
Pharmaforum
Tue, 05/25/21 - 11:56 pm
artificial intelligence
Big Data
RWE
real world evidence
R&D
innovation
Biopharma R&D 'surged' in 2020, but trial productivity levels a mixed bag: report
Fierce Biotech
Wed, 05/19/21 - 10:56 am
R&D
pandemic
COVID-19
Bristol Myers expands Celgene-era deal with Exscientia, taking its AI R&D engine to the next step
Endpoints
Wed, 05/19/21 - 10:33 am
Bristol Myers Squibb
Exscientia
R&D
Celgene
M&A
artificial intelligence
Sanofi begins three-year immunology R&D tie-up with Stanford
Pharmaforum
Thu, 05/6/21 - 10:45 am
Sanofi
Sanford
R&D
immunology
inflammation
Stealthy biotech Janux nabs $125M and joins chase to direct T cells to solid tumors
MedCity News
Wed, 04/21/21 - 11:19 pm
Janux Therapeutics
R&D
solid tumors
CBO Report Shows Enacting Drug Pricing Legislation Will Result In Fewer New Drugs
Forbes
Mon, 04/12/21 - 11:04 pm
legislation
CBO
drug pricing
R&D
Life sciences pumping more cash than ever into R&D, but drug pricing limits could stymie that tide: report
Fierce Pharma
Fri, 04/9/21 - 10:36 am
drug pricing
R&D

Pages